剧透抢先看|第十届医药创新与投资大会初版日程正式发布

Core Insights - The 10th Pharmaceutical Innovation and Investment Conference will be held on October 26-27, 2025, in Nanjing, focusing on global pharmaceutical frontiers and capital trends, gathering top minds in the pharmaceutical innovation and investment fields [1][2]. Conference Information - The conference will take place at Fengda International Hotel, Nanjing, and will cover multiple thematic forums including innovative drug research and development, clinical research, cell and gene therapy, investment mergers and acquisitions, capital markets, and commercial insurance policies [2]. - The agenda includes various sub-forums such as cell and gene therapy, weight loss innovation, clinical data, anti-tumor new drugs, and international roadshows, ensuring comprehensive coverage of the pharmaceutical industry [3][4]. Key Topics - The conference will address core challenges and development trends in the pharmaceutical industry, emphasizing internationalization, investment financing, and regulatory policies, with a focus on the synergy between basic medical insurance and commercial health insurance [5]. - Discussions will include the strategies of Chinese innovative pharmaceutical companies in global markets, particularly in terms of licensing, mergers, and new investment trends [5][6]. Expert Participation - The conference will feature senior experts, clinical specialists, industry leaders, and frontline investors who will share insights on breakthrough technologies, practical experiences in investment mergers, and policy interpretations [4][6]. - Notable speakers include leaders from prestigious institutions and companies, contributing to discussions on the construction of innovative ecosystems and cross-sector collaboration [4][6]. Forum Structure - The conference will be structured around multi-dimensional forums designed to promote deep dialogue and knowledge sharing across clinical, industrial, capital, and policy fields, with three core discussion directions: global strategic layout, capital collaborative innovation, and market trend outlook [6].